Cargando…
Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708305/ https://www.ncbi.nlm.nih.gov/pubmed/29225902 http://dx.doi.org/10.1136/openhrt-2017-000656 |
_version_ | 1783282620578136064 |
---|---|
author | DiNicolantonio, James J Bhutani, Jaikrit OKeefe, James H Crofts, Catherine |
author_facet | DiNicolantonio, James J Bhutani, Jaikrit OKeefe, James H Crofts, Catherine |
author_sort | DiNicolantonio, James J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5708305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57083052017-12-08 Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk DiNicolantonio, James J Bhutani, Jaikrit OKeefe, James H Crofts, Catherine Open Heart Editorial BMJ Publishing Group 2017-11-27 /pmc/articles/PMC5708305/ /pubmed/29225902 http://dx.doi.org/10.1136/openhrt-2017-000656 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Editorial DiNicolantonio, James J Bhutani, Jaikrit OKeefe, James H Crofts, Catherine Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk |
title | Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk |
title_full | Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk |
title_fullStr | Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk |
title_full_unstemmed | Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk |
title_short | Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk |
title_sort | postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708305/ https://www.ncbi.nlm.nih.gov/pubmed/29225902 http://dx.doi.org/10.1136/openhrt-2017-000656 |
work_keys_str_mv | AT dinicolantoniojamesj postprandialinsulinassayastheearliestbiomarkerfordiagnosingprediabetestype2diabetesandincreasedcardiovascularrisk AT bhutanijaikrit postprandialinsulinassayastheearliestbiomarkerfordiagnosingprediabetestype2diabetesandincreasedcardiovascularrisk AT okeefejamesh postprandialinsulinassayastheearliestbiomarkerfordiagnosingprediabetestype2diabetesandincreasedcardiovascularrisk AT croftscatherine postprandialinsulinassayastheearliestbiomarkerfordiagnosingprediabetestype2diabetesandincreasedcardiovascularrisk |